Advertisement
ResearchIn-Press PreviewAIDS/HIVImmunologyOncology
Open Access | 10.1172/JCI177310
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by Desai, S. in: PubMed | Google Scholar
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by Salahuddin, S. in: PubMed | Google Scholar
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by Yusuf, R. in: PubMed | Google Scholar
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by Ranjan, K. in: PubMed | Google Scholar
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by
Gu, J.
in:
PubMed
|
Google Scholar
|
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by Osmani, L. in: PubMed | Google Scholar
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by Lin, Y. in: PubMed | Google Scholar
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by
Mehta, S.
in:
PubMed
|
Google Scholar
|
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by Talmon, R. in: PubMed | Google Scholar
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by Kang, I. in: PubMed | Google Scholar
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by
Kluger, Y.
in:
PubMed
|
Google Scholar
|
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by
Zhao, H.
in:
PubMed
|
Google Scholar
|
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by Schalper, K. in: PubMed | Google Scholar
1Department of Pathology, Yale University School of Medicine, New Haven, United States of America
2Section of Infectious Diseases, Yale University School of Medicine, New Haven, United States of America
3Department of Ophthalmology, Yale University School of Medicine, New Haven, United States of America
4Department of Biostatistics, Yale University School of Medicine, New Haven, United States of America
5Section of Rheumatology, Yale University School of Medicine, New Haven, United States of America
6Department of Electrical and Computer Engineering, Technion - Israel Institute of Technology, Haifa, Israel
7Yale Center for Genome Analysis, Yale University School of Medicine, New Haven, United States of America
Find articles by Emu, B. in: PubMed | Google Scholar
Published June 3, 2025 - More info
Lung cancer is the leading cause of cancer mortality among people with HIV (PWH), with increased incidence and poor outcomes. This study explored whether the tumor microenvironment (TME) of HIV-associated non-small cell lung cancer (NSCLC) limits tumor-specific immune responses. With a matched cohort of NSCLC from PWH and people without HIV (PWOH), we used imaging mass cytometry, linear mixed effects model and AI-based pageRank mathematical algorithm based on spectral graph theory to demonstrate that HIV-associated tumors demonstrate differential distribution of tumor infiltrating CD8+ and CD4+ T cells, enriched for the expression of PD-1 and Lag-3, as well as activation and proliferation markers. We also demonstrate higher expression of immunoregulatory molecules (PD-L1, PD-L2, B7-H3, B7-H4, IDO1 and VISTA), among tumor-associated macrophages. Discrimination of cells between tumors from PWH versus PWOH was confirmed by spectral graph theory with 84.6% accuracy. Furthermore, we noted differences in spatial orientation of immune cells within the TME of PWH compared to PWOH. Additionally, cells from PWH, compared to PWOH, exhibited decreased tumor killing when exposed to HLA-matched NSCLC cell lines. In conclusion, our study demonstrates that the HIV-associated tumor microenvironment sustains a unique immune landscape, with evidence of immune cells with enhanced immunoregulatory phenotypes and impaired anti-tumor responses, with implications for response to immune checkpoint blocker therapies.